• Users Online: 393
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


The hallmarks of cancer and their therapeutic targeting in current use and clinical trials

Al-Bedeary Samir, Getta Hisham Arif, Al-Sharafi Dhay

Year : 2020| Volume: 9| Issue : 1 | Page no: 1-10

   This article has been cited by
1 Toxoplasma gondii-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide
Cherine A. Ismail, Maha M. Eissa, Maha R. Gaafar, Layla K. Younis, Nahla El Skhawy
Medical Oncology. 2023; 40(5)
[Pubmed]  [Google Scholar] [DOI]
2 Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting
Maha M. Eissa, Maha R. Gaafar, Layla K. Younis, Cherine A. Ismail, Nahla El Skhawy
Infectious Agents and Cancer. 2023; 18(1)
[Pubmed]  [Google Scholar] [DOI]
3 Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical Challenges
Nihal Mostafa, Ahmed Salem, Somaya Z. Mansour, Sawsan M. El-Sonbaty, Fatma S. M. Moawed, Eman I. Kandil
Technology in Cancer Research & Treatment. 2022; 21: 1533033822
[Pubmed]  [Google Scholar] [DOI]
4 Cytotoxic and Antioxidant Potential of Chloroform Extract of Holothuria tubulosa Gmelin, 1791
M. Dogangünes, A. Türker, H. Günes, M. Alper
Russian Journal of Marine Biology. 2021; 47(6): 498
[Pubmed]  [Google Scholar] [DOI]
5 Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment
Silvia Vivarelli,Saverio Candido,Giuseppe Caruso,Luca Falzone,Massimo Libra
Cancers. 2020; 12(12): 3636
[Pubmed]  [Google Scholar] [DOI]


Read this article